GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » Stock Based Compensation

Sinclair Pharma (XPAR:SPH) Stock Based Compensation : €1.39 Mil (TTM As of Jun. 2018)


View and export this data going back to . Start your Free Trial

What is Sinclair Pharma Stock Based Compensation?

Sinclair Pharma's Stock Based Compensation for the six months ended in Jun. 2018 was €0.77 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2018 was €1.39 Mil.


Sinclair Pharma Stock Based Compensation Historical Data

The historical data trend for Sinclair Pharma's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinclair Pharma Stock Based Compensation Chart

Sinclair Pharma Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Dec17
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.41 0.74 2.45 2.73 1.30

Sinclair Pharma Semi-Annual Data
Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Jun17 Dec17 Jun18
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.17 1.25 0.70 0.61 0.77

Sinclair Pharma Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2018 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.39 Mil.


Sinclair Pharma Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinclair Pharma (XPAR:SPH) Business Description

Traded in Other Exchanges
N/A
Address
Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.